Clarke et al. [5] demonstrated that BMCC1 RNA expression is elevated in prostate cancer and metastases compared with benign tissue, indicating that BMCC1 may be functioning differently in different cancers and tissue types. The gene discussed is PRUNE2; the disease is prostate cancer.